Damien Ambrosetti
Nice, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications
Uncertainty-aware AI for tumor subtyping with histology and immunohistochemistry: A multi-center study in Renal Cell Carcinoma.
Journal: Computer methods and programs in biomedicine
Published: October 10, 2025
Renal Cell Carcinoma subtyping: Learning from multi-resolution localization.
Journal: Computer methods and programs in biomedicine
Published: June 20, 2025
Hypusination of the translation factor eIF5A regulates mitochondrial tRNA processing to promote prostate cancer aggressiveness.
Journal: Nature communications
Published: November 29, 2024
Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulation.
Journal: iScience
Published: November 19, 2024
Onychocytic Matricoma: A Clinical, Dermoscopic, and Pathological Analysis of 14 Cases.
Journal: The American Journal of dermatopathology
Published: March 21, 2024
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 13, 2023
Improving CNNs classification with pathologist-based expertise: the renal cell carcinoma case study.
Improving CNNs classification with pathologist-based expertise: the renal cell carcinoma case study.
Journal: Scientific reports
Published: January 27, 2023
A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma.
Journal: Molecular oncology
Published: December 04, 2022
Onychomatricoma: a clinicopathological, immunohistochemical, and molecular study of 10 cases highlighting recurrent RB1 deletion and the potential diagnostic value of LEF-1.
Journal: Histopathology
Published: October 17, 2022
Last Updated: 09/26/2026